Alphatec Holdings (ATEC) Aktienübersicht
Alphatec Holdings, Inc. ist ein Medizintechnikunternehmen, das Technologien für die chirurgische Behandlung von Wirbelsäulenerkrankungen in den Vereinigten Staaten und international konzipiert, entwickelt und vorantreibt. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 4/6 |
| Künftiges Wachstum | 4/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 2/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für ATEC festgestellt.
ATEC Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Alphatec Holdings, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$9.31 |
| 52-Wochen-Hoch | US$23.29 |
| 52-Wochen-Tief | US$6.82 |
| Beta | 0.86 |
| 1 Monat Veränderung | 1.09% |
| 3 Monate Veränderung | 23.80% |
| 1 Jahr Veränderung | -37.81% |
| 3 Jahre Veränderung | -37.52% |
| 5 Jahre Veränderung | -27.94% |
| Veränderung seit IPO | -91.36% |
Aktuelle Nachrichten und Updates
Seeking Alpha • Aug 07
Alphatec: Straightening Its Back
Summary Alphatec reports 15% revenue growth and improved operating leverage, with realistic break-even levels approaching despite ongoing net losses and dilution. Alphatec maintains $882 million in sales guidance and raises adjusted EBITDA guidance to $140 million, signaling confidence in margin improvements and operational progress. Leverage concerns are easing as free cash flow turns positive, dilution slows, and interest expenses decline, aided by strong EOS imaging technology growth. Trading at just over 2x sales, Alphatec offers speculative appeal given robust growth, margin gains, and a significant discount to peer multiples. Read the full article on Seeking Alpha
Narrative-Update • Aug 05
ATEC: 2026 Revenue Mix Will Support Constructive Upside Case
Analysts have adjusted their price target on Alphatec Holdings from $24.00 to about $22.41. The change reflects updated assumptions around discount rate, revenue growth, profit margin, and future P/E estimates.Recent updates
Seeking Alpha • Aug 07
Alphatec: Straightening Its Back
Summary Alphatec reports 15% revenue growth and improved operating leverage, with realistic break-even levels approaching despite ongoing net losses and dilution. Alphatec maintains $882 million in sales guidance and raises adjusted EBITDA guidance to $140 million, signaling confidence in margin improvements and operational progress. Leverage concerns are easing as free cash flow turns positive, dilution slows, and interest expenses decline, aided by strong EOS imaging technology growth. Trading at just over 2x sales, Alphatec offers speculative appeal given robust growth, margin gains, and a significant discount to peer multiples. Read the full article on Seeking AlphaNarrative-Update • Aug 05
ATEC: 2026 Revenue Mix Will Support Constructive Upside Case
Analysts have adjusted their price target on Alphatec Holdings from $24.00 to about $22.41. The change reflects updated assumptions around discount rate, revenue growth, profit margin, and future P/E estimates.
Narrative-Update • Jul 20
ATEC: 2026 Surgical Revenue Outlook Will Drive Future Upside Potential
Analysts have trimmed their price target for Alphatec Holdings from $17.33 to $16.00, citing updated fair value estimates, a slightly lower discount rate, and an adjusted future P/E assumption that reflects a more measured approach to valuation multiples. What's in the News Alphatec Holdings issued earnings guidance for the fiscal year ending December 31, 2026, providing investors with updated expectations for the business.Narrative-Update • Jul 06
ATEC: 2026 Revenue Outlook Will Support Constructive Upside Case
Analysts have trimmed their price target for Alphatec Holdings to $24.00 from $28.00, reflecting updated assumptions for revenue growth, profit margins, the discount rate, and the future P/E multiple. What's in the News for Alphatec Holdings Alphatec Holdings issued earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $882 million.
Narrative-Update • Jun 22
ATEC: Legal Overhang And 2026 Outlook Will Support Future Upside
Analysts have maintained their $11.00 price target for Alphatec Holdings, citing updated model assumptions that reflect slightly adjusted discount rates, revenue growth expectations, profit margins, and future P/E estimates. What’s in the News for Alphatec Holdings Schall Law Firm has begun an investigation into Alphatec Holdings, Inc.Narrative-Update • Jun 05
ATEC: New Bank Facility And 2026 Outlook Will Support Upside
Analysts have trimmed their price target for Alphatec Holdings from $20.00 to $11.00, citing updated assumptions for revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change. What's in the News Alphatec reported Q1 2026 total revenue of $192 million, with surgical revenue growth of 17% and total revenue growth of 14%, according to recent earnings coverage (source: Alphatec Reports Strong Q1 2026 Growth and Secures New Bank Facility).Narrative-Update • May 14
ATEC: 2026 Surgical Revenue Focus Will Support Future Upside Potential
Analysts have reduced their price target for Alphatec Holdings from about $24.62 to about $17.33 as they adjust assumptions for discount rate, revenue growth, profit margin, and future P/E in their models. What's in the News Alphatec Holdings issued earnings guidance for the fiscal year ending December 31, 2026, targeting total revenue of about $882 million, with surgical revenue expected to grow 17% as part of that outlook (corporate guidance).Narrative-Update • Apr 29
ATEC: 2026 Revenue Guidance Will Drive Constructive Upside Case
Analysts have kept their $28.00 price target for Alphatec Holdings unchanged, noting that only modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E offset one another in their valuation work. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, indicating no change to its previously communicated outlook.Narrative-Update • Apr 15
ATEC: 2026 Revenue Outlook Will Support Bullish Return Potential
Analysts have kept their $28.00 price target on Alphatec Holdings unchanged, citing updated assumptions that include a higher discount rate, stronger modeled revenue and profit margins, and a lower future P/E multiple that together balance out in their valuation work. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, maintaining its outlook for that period.Narrative-Update • Mar 31
ATEC: 2026 Revenue Outlook And Biologics Partnership Will Support Upside
Analysts have trimmed their price target for Alphatec Holdings from $22.00 to $20.00, citing updated assumptions for revenue growth, profit margins and future P/E that together point to a more measured long term outlook for the shares. What's in the News Reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million, described as about $126 million or 17% above full year 2025 revenue (Corporate Guidance).Narrative-Update • Mar 17
ATEC: 2026 Revenue Outlook And Spine Biologics Partnership Will Support Upside
Analysts have left their $28.00 price target for Alphatec Holdings unchanged, citing a slightly higher assumed discount rate, a moderated revenue growth outlook, stronger projected profit margins, and a lower future P/E as key factors supporting the steady valuation. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million.Narrative-Update • Mar 03
ATEC: 2026 Revenue Outlook And Biologics Partnership Will Support Upside Potential
Analysts have adjusted their Alphatec Holdings target to $24.62, reflecting updated assumptions that combine slightly lower expected revenue growth with higher projected profit margins and a reduced future P/E multiple, while applying a somewhat higher discount rate. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million, described as about $126 million or 17% higher than full year 2025 revenue (company guidance).Narrative-Update • Feb 17
ATEC: 2026 Revenue Guidance And Spine Biologics Deal Will Drive Upside
Analysts have maintained their $28.00 price target for Alphatec Holdings, citing steady model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions as reasons to hold their prior valuation line. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of approximately $890m for the year ended December 31, 2026 (Corporate Guidance).Narrative-Update • Feb 03
ATEC: Partnership And 2026 Revenue Outlook Will Reshape Spine Biologics Opportunity
Analysts have raised their fair value estimate for Alphatec Holdings from $23.00 to $28.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that they believe better reflect the company’s current outlook. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of about $890 million compared to full year 2025 (Corporate Guidance).Narrative-Update • Jan 20
ATEC: Higher 2026 Revenue Outlook And New Partnership Will Support Upside
Analysts have lifted their price target on Alphatec Holdings from US$14.00 to US$22.00, citing updated assumptions around discount rate, revenue growth, profit margins and future P/E as the key drivers of the change. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of approximately US$890 million for the year.Analyseartikel • Jan 06
Are Alphatec Holdings, Inc. (NASDAQ:ATEC) Investors Paying Above The Intrinsic Value?
Key Insights Alphatec Holdings' estimated fair value is US$17.32 based on 2 Stage Free Cash Flow to Equity Alphatec...Narrative-Update • Jan 06
ATEC: Higher 2025 Revenue Guidance Will Support A More Optimistic Outlook
Analysts have inched their price target for Alphatec Holdings higher to about $24.62 from $24.00, reflecting small tweaks to fair value estimates, discount rate assumptions, and a slightly higher future P/E multiple in their models. What's in the News Alphatec Holdings raised earnings guidance for the fiscal year ending December 31, 2025, indicating updated expectations for the business outlook.Narrative-Update • Dec 14
ATEC: Revenue Will Reach 760 Million As Outlook Remains Favorable
Analysts have modestly raised their price target on Alphatec Holdings by 0.25 dollars to 24.00 dollars, reflecting slightly higher long term valuation multiples despite only marginal tweaks to growth, margin and discount rate assumptions. What's in the News Alphatec Holdings raised its earnings guidance for fiscal 2025, now expecting total revenue to increase 24 percent to 760 million dollars, compared with the prior outlook of 742 million dollars (company guidance filing) Valuation Changes Fair Value Estimate has risen slightly to 24.00 dollars from 23.75 dollars, reflecting a modest uplift in long term valuation.Narrative-Update • Nov 29
ATEC: Revenue Will Reach $760 Million As Guidance Increases And Outlook Remains Steady
Analysts have maintained their fair value price target for Alphatec Holdings at $23.75, citing only minor adjustments to underlying financial assumptions along with a steady outlook for growth and profitability. What's in the News Alphatec Holdings raised its earnings guidance for the fiscal year ending December 31, 2025, reflecting increased confidence in the company's outlook (Key Developments).Narrative-Update • Nov 15
ATEC: Total Revenue Will Reach $760 Million Next Year
Narrative Update on Alphatec Holdings: Analyst Price Target Revision Analysts have increased their price target for Alphatec Holdings from $20.54 to $23.75. This change reflects revised financial assumptions and updated expectations for the company’s future performance.Narrative-Update • Nov 01
ATEC: Improved Margins And Revenue Projections Will Shape Future Performance
Analysts have raised their price target for Alphatec Holdings from $19.41 to $20.54 per share, citing improved profit margin forecasts and stronger projected revenue growth as key reasons for the increased valuation. What's in the News Alphatec Holdings, Inc.Analyseartikel • Oct 05
Not Many Are Piling Into Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Yet
With a median price-to-sales (or "P/S") ratio of close to 2.8x in the Medical Equipment industry in the United States...Narrative-Update • Sep 20
Expanding Spine Care And Integrated Tech Will Drive Future Opportunities
The slight increase in Alphatec Holdings’ future P/E ratio reflects higher growth expectations, which has contributed to a modest rise in its consensus analyst price target from $18.95 to $19.41. What's in the News Raised full-year 2025 revenue guidance to $742 million, up 21% year-over-year, surpassing previous forecast of $734 million.Analyseartikel • Jul 28
Are Investors Undervaluing Alphatec Holdings, Inc. (NASDAQ:ATEC) By 43%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Alphatec Holdings fair value estimate is US$19.10 Current...Analyseartikel • Jul 09
Should You Investigate Alphatec Holdings, Inc. (NASDAQ:ATEC) At US$11.60?
While Alphatec Holdings, Inc. ( NASDAQ:ATEC ) might not have the largest market cap around , it led the NASDAQGS...Neues Narrative • May 27
Robotics And Minimally Invasive Techniques Will Expand Spine Care
Innovative spine solutions and expanding minimally invasive offerings position Alphatec for sustained revenue growth and margin expansion amid rising global spine care demand.Analyseartikel • May 11
Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock Rockets 25% But Many Are Still Ignoring The Company
Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shares have had a really impressive month, gaining 25% after a shaky period...Analyseartikel • Apr 20
Alphatec Holdings (NASDAQ:ATEC) Is Making Moderate Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Mar 01
Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
Shareholders of Alphatec Holdings, Inc. ( NASDAQ:ATEC ) will be pleased this week, given that the stock price is up 18...Analyseartikel • Jan 18
Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock Rockets 31% But Many Are Still Ignoring The Company
Despite an already strong run, Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shares have been powering on, with a gain of 31...Analyseartikel • Dec 19
Here's Why Alphatec Holdings (NASDAQ:ATEC) Can Afford Some Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Dec 03
Alphatec: A Big Recovery
Summary Alphatec, a medtech company focused on spine solutions, has faced investor concerns due to continued losses, cash burn, and increasing debt despite revenue growth. Shares plunged 40% after Q2 earnings, but have recovered following the release of the third quarter results following management's comments about positive cash flow in Q4. Management's optimistic outlook is further backed up by significant improvement in EBITDA seen in 2025. Despite the positive reaction, Alphatec still needs to prove its ability to reduce debt and avoid further dilution while executing its growth plans. Read the full article on Seeking AlphaAnalyseartikel • Nov 01
Alphatec Holdings, Inc. (NASDAQ:ATEC) Soars 50% But It's A Story Of Risk Vs Reward
Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shareholders would be excited to see that the share price has had a great...Aktionärsrenditen
| ATEC | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | -2.2% | 3.0% | 4.0% |
| 1Y | -37.8% | -13.3% | 20.7% |
Rendite im Vergleich zur Industrie: ATEC unter dem Niveau der Branche US Medical Equipment , die im vergangenen Jahr eine Rendite von -13.3% erzielte.
Rendite vs. Markt: ATEC hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 20.7 erzielte.
Preisvolatilität
| ATEC volatility | |
|---|---|
| ATEC Average Weekly Movement | 8.4% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: ATEC hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: ATECDie wöchentliche Volatilität (8%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1990 | 913 | Pat Miles | www.atecspine.com |
Alphatec Holdings, Inc. ist ein Medizintechnikunternehmen, das Technologien für die chirurgische Behandlung von Wirbelsäulenerkrankungen in den Vereinigten Staaten und international konzipiert, entwickelt und vorantreibt. Das Unternehmen fertigt und vertreibt Implantate, Instrumente, bildgebende Geräte und Ersatzteile. Es bietet die Produktplattform Alpha InformatiX an, einschließlich des EOS-Bildgebungssystems, das eine Ganzkörperbildgebung ermöglicht; das SafeOp Neural InformatiX System, das die Überwachung von elektromyographischen, somatosensorisch evozierten und motorisch evozierten Potentialen automatisiert; und Valence, ein intraoperatives System, das Navigation und Robotik in Wirbelsäuleneingriffe integriert, sowie Sigma Prone TransPsoas (PTP) Access und PTP Patient Positioning Systems.
Alphatec Holdings, Inc.'s Grundlagenzusammenfassung
| ATEC grundlegende Statistiken | |
|---|---|
| Marktanteil | US$1.42b |
| Gewinn(TTM) | -US$109.99m |
| Umsatz(TTM) | US$815.05m |
1.8x
Kurs-Umsatz-Verhältnis-13.1x
Kurs-Gewinn-Verhältnis Ist ATEC zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| ATEC Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$815.05m |
| Kosten der Einnahmen | US$237.69m |
| Bruttogewinn | US$577.37m |
| Sonstige Ausgaben | US$687.36m |
| Gewinn | -US$109.99m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -0.71 |
| Bruttomarge | 70.84% |
| Nettogewinnspanne | -13.50% |
| Schulden/Eigenkapital-Verhältnis | 4,991.8% |
Wie hat sich ATEC auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/07 11:03 |
| Aktienkurs zum Tagesende | 2026/08/07 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Alphatec Holdings, Inc. wird von 27 Analysten beobachtet. 14 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Matthew Miksic | Barclays |
| Vikramjeet Chopra | BMO Capital Markets Equity Research |
| Caitlin Cronin | Canaccord Genuity |